5605
post-template-default,single,single-post,postid-5605,single-format-standard,stockholm-core-2.4,qodef-qi--no-touch,qi-addons-for-elementor-1.6.7,select-theme-ver-9.5,ajax_fade,page_not_loaded,,qode_menu_,wpb-js-composer js-comp-ver-7.9,vc_responsive,elementor-default,elementor-kit-38031
Title Image

The Supreme Court Will Hear Myriad Case Again

December 5, 2012 In Blog, Patents, Technology By Tiffany Mahmood

The Supreme Court Will Hear Myriad Case Again

The Supreme Court has granted certiorari to review the AMP v. USPTO case relating to the Myriad patents on the BRCA1 and BRCA2 genes. The Court agreed to review the case only on the issue of the validity of patent genes under 35 U.S.C. §101. This is the second time that the Supreme Court has granted cert on the Myriad case, the first being in March when the Court sent the case back down to the Federal Circuit for reconsideration in light of Mayo v. Prometheus.

Tiffany Mahmood

Tiffany Mahmood is a second year student at Fordham University School of Law and the incoming Editor-in-Chief for Volume 24 of the IPLJ. Originally from London, England, Tiffany studied to become a wig-wearing British Barrister before moving to the United States. She is a Senior Conference Fellow at the Fordham IP Institute, assisting in organizing the annual Fordham Intellectual Property Conference, and plans to pursue a career in Patent law in the U.S.